Product Search |
|
| Input Product Name Or Cas No. |
Category |
Products |
2-((4-Methoxybenzyloxy)carbonyl)-2-(4-(4 |
trans-(4-(Methylamino)cyclohexyl)methane |
2-Hexyldecyl 2-propenoate |
Methyl 3-[4-[(6-hydroxyhexyl)oxy]phenyl] |
2-Hydroxyethyl 4-ethenylbenzoate |
1-Ethenyl-4-(octyloxy)benzene |
4-Methoxyphenyl (2E)-3-[4-[[6-[(1-oxo-2- |
Methyl (2E)-3-[4-[4-[(1-oxo-2-propen-1-y |
3-[3-(4-Ethenylphenoxy)propyl]-1,1,1,5,5 |
4-[[(2E)-3-(4-Methoxyphenyl)-1-oxo-2-pro |
4-Cyanophenyl 3-[3-methoxy-4-[4-[(1-oxo- |
2-Propenoic acid, 4-(3,3-dimethylbutoxy) |
2-Propenoic acid, 4-[[tris(1-methylethyl |
4-Vinylphenyl cinnamate |
3-[3,3,3-Trimethyl-1,1-bis[(trimethylsil |
2-[(1-Oxo-3-phenyl-2-propen-1-yl)oxy]eth |
Methyl 3-[4-[[6-[(1-oxo-2-propen-1-yl)ox |
Methyl 3-[4-[2-[(1-oxo-2-propen-1-yl)oxy |
(1S,2S,4S)-1,7,7-Trimethylbicyclo[2.2.1] |
1-Ethyl-1,2,2-trimethylpropyl 2-methyl-2 |
1,2-Dimethylcyclopentyl 2-methyl-2-prope |
[1,1′-Bicyclohexyl]-1-yl 2-methyl-2-pr |
bicyclo[2.2.1]hept-5-en-2-ylmethyl ethyl |
1-(1,1-Dimethylethyl)-1,2,2-trimethylpro |
(2-Nitrophenyl)methyl 2-methyl-2-propeno |
Isobornyl methacrylate |
(4-benzoylphenyl)di-p-tolylsulfonium tri |
1-(p-tolyl)-1H-benzo[b]thiophen-1-ium tr |
Sulfonium, [3-[(1E)-2-[4-(diphenylamino) |
dimethyl(3-(9-oxo-9H-thioxanthen-2-yl)ph |
bis(4-(tert-butyl)phenyl)iodonium 1,1,2, |
bis(4-(tert-butyl)phenyl)iodonium 1,1,2, |
bis(4-(tert-butyl)phenyl)iodonium 1,1,2, |
bis(4-(tert-butyl)phenyl)iodonium 1,1,2, |
(4-(tert-butyl)phenyl)diphenylsulfonium |
diphenyl(p-tolyl)sulfonium ((perfluorobu |
diphenyl(p-tolyl)sulfonium bis((perfluor |
(4-(tert-butyl)phenyl)diphenylsulfonium |
Thiophenium, tetrahydro-1-(2-oxo-2-pheny |
(4-(tert-butyl)phenyl)diphenylsulfonium |
Triphenylsulfonium p-styrenesulfonate |
triphenylsulfonium 4-(tert-butyl)benzene |
5-Azoniaspiro[4.4]nonane tetrafluorobora |
1,1-Dimethoxycyclopentane |
3-Hydroxy-2,2-dimethylpropyl 2-methyl-2- |
5-(Methoxycarbonyl)-2-adamantanone |
Dibutyl cyclohexane-1,2-dicarboxylate |
Chloromethyl cyclohexyl carbonate |
4-(Vinyloxy)butyl methacrylate |
1-(2-Methyl-1-oxo-2-propen-1-yl)-2-pyrro |
|
Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| NX52218 | 5-Methylchroman-4-one | 18385-68-7 | 95% |
| NX52219 | 6-Methoxy-4-chromanone | 5802-17-5 | 95% |
| NX52220 | 2-(3-methylbenzyl)-1,3,4-oxadiazole | 1026573-04-5 | 95% |
| NX52221 | 2-Butyl-1,3,4-oxadiazole | 944892-25-5 | 95% |
| NX52222 | 4-Bromo-1H-indazol-3-amine | 914311-50-5 | 95% |
| NX52223 | 7,8-difluorochroman-4-one | 890840-90-1 | 95% |
| NX52224 | 8-(trifluoromethyl)chroman-4-one | 890839-66-4 | 95% |
| NX52225 | 5,7-Difluorochroman-4-amine | 886762-87-4 | 95% |
| NX52226 | 7,8-difluorochroman-4-amine | 886762-83-0 | 95% |
| NX52227 | 4-Methoxy-1H-indazol-3-amine | 886362-07-8 | 95% |
| NX52228 | 5,7-Difluorochroman-4-one | 844648-22-2 | 95% |
| NX52229 | 8-fluorochroman-4-amine | 791043-28-2 | 95% |
| NX52230 | 7-fluorochroman-4-amine | 774163-31-4 | 95% |
| NX52231 | 3-Amino-6-methoxy-1H-indazole | 511225-17-5 | 95% |
| NX52232 | 2-(1-methylcyclopropyl)-1,3,4-Oxadiazole | 353238-51-4 | 95% |
| NX52233 | 4-methoxy-1H-indazole | 351210-06-5 | 95% |
| NX52234 | 2-(2-phenylpropan-2-yl)-1,3,4-oxadiazole | 252253-32-0 | 95% |
| NX52235 | 2-[1-(1,3-benzodioxol-5-yl)-1-methylethyl]-1,3,4-Oxadiazole | 251958-52-8 | 95% |
| NX52236 | 2-(1-methylethyl)-1,3,4-Oxadiazole | 149324-24-3 | 95% |
| NX52237 | 5-methoxy-1H-indazol-3-amine | 58514-96-8 | 95% |
| NX52238 | 4-Chloro-1H-indazol-3-amine | 20925-60-4 | 95% |
| NX52239 | 2-benzyl-1,3,4-oxadiazole | 13148-63-5 | 95% |
| NX52240 | 2-propyl-1,3,4-Oxadiazole | 13148-62-4 | 95% |
| NX52241 | 2-ethyl-1,3,4-Oxadiazole | 13148-61-3 | 95% |
| NX52242 | 2-methyl-1,3,4-Oxadiazole | 3451-51-2 | 95% |
| NX52243 | 2-(4-methoxyphenyl)-1,3,4-oxadiazole | 829-35-6 | 95% |
| NX52244 | 2-phenyl-1,3,4-Oxadiazole | 825-56-9 | 95% |
| NX52245 | 7-bromo-1,2,3,4-tetrahydrocyclopenta[b]indol-2-amine | 1196037-58-7 | 95% |
| NX52246 | methyl 5-iodo-1-methyl-1H-pyrazole-3-carboxylate | 1193244-87-9 | 95% |
| NX52247 | 4-bromo-1H-indol-7-ol | 1167056-91-8 | 95% |
|
|
|
|